Survival and Functional Status Outcomes in Heart Transplant Recipients: An Analysis of Organs From Donors Who Overdosed
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70725 ↗At a glance
Journal article in Clinical Transplantation, 2026. Written by Jennifer L Siebert and 3 co-authors. Institution: M. Louise Fitzpatrick College of Nursing, Villanova University, Villanova, Pennsylvania, USA. Major MEDLINE topics: Heart Transplantation, Drug Overdose, Tissue Donors, Transplant Recipients. 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Introduction
Escalating deaths associated with the opioid crisis has increased availability of transplant organs from donors who died of a drug overdose, yet perception of these organs as “increased risk” contributes to their unnecessary discard. Previous research addressing this issue has focused solely on survival outcomes, but quality of life is also a crucial factor in determining transplant success.
Methods
In this study, a secondary analysis of data representing adult, first‐time heart transplant recipients from the Scientific Registry of Transplant Recipients between January 1, 2016, and March 1, 2020 was conducted. Logistic regression modeled one‐year survival and functional status at one‐year, and Cox proportional hazards modeled survival time post‐transplant. Non‐inferiority testing compared survival and functional status outcomes for overdose donor ( n = 2240) and non‐overdose donor ( n = 9427) organ recipients.
Results
When not controlling for significant covariates, one‐year survival rates, post‐transplant survival time, and one‐year Karnofsky scores were at least as good or better for overdose donor organ recipients compared to non‐overdose organ recipients based on a‐priori non‐inferiority thresholds; estimated OR for one‐year survival is 1.0207 (95% CI [0.863, 1.213]), estimated hazards ratio is 0.9425 (95% CI [0.823, 1.079]), and estimated OR for having high one‐year functional status is 0.9035 (95% CI [0.769, 1.066]). Controlling for significant covariates, one‐year survival (OR 0.9613, 95% CI [0.790, 1.176]) and functional status (OR 1.0181, 95% CI [0.855, 1.218]) remained at least as good or better for overdose donor recipients; survival time was also estimated to be as good or better for overdose organ recipients when controlling for significant covariates (HR 0.9611, 95% CI [0.828, 1.115]), but not to the level of statistical significance based on the non‐inferiority threshold.
Conclusion
Overall, post‐transplant survival times, one‐year survival rates, and one‐year functional status are similar for overdose and non‐overdose organ heart transplant recipients. These findings support a broader utilization of the drug overdose donor pool, especially as the demand for heart transplantation increases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- M. Louise Fitzpatrick College of Nursing, Villanova University, Villanova, Pennsylvania, USA.
- Department of Mathematics and Statistics, College of Arts & Sciences, Villanova University, Villanova, Pennsylvania, USA.
ORCID profiles: Jennifer L Siebert, James D Mendez, Jennifer Yost
Cite
APA
Siebert, J. L., Mendez, J. D., Yost, J., & Bernhardt, P. W. (2026). Survival and Functional Status Outcomes in Heart Transplant Recipients: An Analysis of Organs From Donors Who Overdosed. Clinical Transplantation. https://doi.org/10.1111/ctr.70725
Vancouver
Siebert JL, Mendez JD, Yost J, Bernhardt PW. Survival and Functional Status Outcomes in Heart Transplant Recipients: An Analysis of Organs From Donors Who Overdosed. Clinical Transplantation. 2026. doi:10.1111/ctr.70725
BibTeX
@article{Siebert2026,
author = {Siebert, Jennifer L and Mendez, James D and Yost, Jennifer and Bernhardt, Paul W},
title = {Survival and Functional Status Outcomes in Heart Transplant Recipients: An Analysis of Organs From Donors Who Overdosed},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70725}
}
EUVIMED